Hospice News
JANUARY 30, 2024
billion by 2027, up from $2 billion in 2020. As of January 2022, 50 publicly traded companies have emerged in the United States that seek to market psychedelic therapies, including three valued at more than $1 billion, a JAMA Network study found. The authors cited projections that the U.S. market for those substances would reach $10.75
Hospice News
JANUARY 10, 2023
Oregon in 2020 essentially decriminalized the personal use of a number of drugs that remain illegal at the federal level. billion by 2027, up from $2 billion in 2020. Neither bill passed before the congressional term ended following the midterm elections. The authors cited projections that the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
MAY 10, 2022
Case in point, the 15 deals the company completed in 2020 collectively grew EBITDA by 51.7% The company pointed toward two transactions in particular as recent success stories: its March 2020 joint venture with the San Diego-area health system Scripps Health and its purchase of First Call Hospice in June that same year.
Solace
JANUARY 6, 2023
California’s law won’t go into effect until 2027 while Vermont’s began with the new year. In 2020, Oregonians passed Ballot Measure 109 which legalized the use of psilocybin for use in counseling in a controlled environment for people over 21. New York is the latest state to allow “organic reduction” also known as “human composting.”
Hospice Law Blog
OCTOBER 6, 2021
The moratorium will end either three hundred and sixty five (365) days from the date the California State Auditor publishes a report on hospice licensure or when the provisions of the Bill are repealed on January 1, 2027, whichever is sooner.
Hospice News
MAY 23, 2023
billion industry by 2027, Forbes reported last July. 2020 and is now worth an estimated $375 million. Oregon in 2020 decriminalized a number of drugs that remain illegal federally. The focus to date has been concentrated on three areas: mental health, palliative and end-of-life care. Clinical psychedelics may become a $6.85
Expert insights. Personalized for you.
181 
Let's personalize your content